Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Lupin gets European Commission nod for NaMuscla

      Lupin gets European Commission nod for NaMuscla

      Medical Dialogues Bureau9 Jan 2019 9:30 AM IST
      "The EC approval follows the positive opinion which was issued by the Committee for Medicinal Products for Human Use (CHMP), the scientific committee...
      New York City launches $100 million universal health insurance program

      New York City launches $100 million universal health insurance program

      Medical Dialogues Bureau9 Jan 2019 9:00 AM IST
      NEW YORK: New York City recently launched a $100 million health insurance program to cover 600,000 uninsured city residents, including those unable to...
      Relief to Wockhardt: HC sets aside ban on Ace Proxyvon- Aceclofenac, Paracetamol, Rabeprazole Combo

      Relief to Wockhardt: HC sets aside ban on Ace Proxyvon- Aceclofenac, Paracetamol, Rabeprazole Combo

      Medical Dialogues Bureau8 Jan 2019 12:15 PM IST
      In an interim order, the court had earlier said that no coercive steps be taken against Wockhardt for sale of stocks of its banned anti-inflammatory...
      Lupin gets USFDA nod for generic schizophrenia drug

      Lupin gets USFDA nod for generic schizophrenia drug

      Medical Dialogues Bureau8 Jan 2019 12:10 PM IST
      New Delhi: Drug maker Lupin Monday said it has received approval from the US health regulator to market Lurasidone Hydrochloride tablets, used in the...
      Building speciality portfolio of around 150 products in next 3 fiscal yrs: Aurobindo

      Building speciality portfolio of around 150 products in next 3 fiscal yrs: Aurobindo

      Medical Dialogues Bureau8 Jan 2019 12:10 PM IST
      New Delhi: Aurobindo Pharma is focussing on building a diverse speciality portfolio of nearly 150 products with an addressable market size of USD...
      Eli Lilly to acquire Loxo Oncology for $8 billion

      Eli Lilly to acquire Loxo Oncology for $8 billion

      Medical Dialogues Bureau8 Jan 2019 12:09 PM IST
      Washington: -Pharmaceutical giant Eli Lilly will acquire cancer treatment specialist Loxo Oncology in a cash deal valued at around $8 billion, the...
      Takeda unlikely to sell OTC drug business - CEO

      Takeda unlikely to sell OTC drug business - CEO

      Medical Dialogues Bureau8 Jan 2019 9:08 AM IST
      TOKYO - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it closes a...
      Rs 8100 crore bank loan fraud case: Sterling Biotech receives non bailable warrants

      Rs 8100 crore bank loan fraud case: Sterling Biotech receives non bailable warrants

      Medical Dialogues Bureau7 Jan 2019 9:15 AM IST
      Additional Sessions Judge Satish Kumar Arora allowed the Enforcement Directorate's plea seeking issuance of NBW against Sterling Biotech Ltd (SBL)...
      Rs 11000 crore benefit to people from fixing drug prices: Minister

      Rs 11000 crore benefit to people from fixing drug prices: Minister

      Medical Dialogues Bureau6 Jan 2019 9:35 AM IST
      The Minister, who was replying during the Question Hour, said that to make medicines affordable, the government capped prices of 855 medicines and...
      Abbvie to record $4 billion impairment charges on Stemcentrx assets

      Abbvie to record $4 billion impairment charges on Stemcentrx assets

      Medical Dialogues Bureau6 Jan 2019 9:00 AM IST
      The drugmaker acquired Rova-T through its $5.8 billion acquisition of Stemcentrx in 2016, as it aimed to enter the broad and lucrative arena of solid...
      Nestle Maggi Controversy: SC revives Rs 640 crore class action suit

      Nestle Maggi Controversy: SC revives Rs 640 crore class action suit

      Medical Dialogues Bureau4 Jan 2019 1:30 PM IST
      The Consumer Affairs Ministry had in 2015 filed a complaint against Nestle India before the NCDRC using a provision for the first time in the nearly...
      Eris Lifesciences joins hands with Medtronic for diabetes monitoring initiative

      Eris Lifesciences joins hands with Medtronic for diabetes monitoring initiative

      Medical Dialogues Bureau4 Jan 2019 10:30 AM IST
      The two companies will utilize their respective strengths in helping patients monitor their diabetes better.New Delhi: In a first of its kind...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok